Correlations of high miRNA expressions with traditional proteins and prognosis of breast cancer

1 Liu L, Yang Y, Guo Q, Ren B, Peng Q, Zou L, et al. Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review. Radiat Oncol. 2020;15(1):17. DOI: 10.1186/s13014-020-1463-1 Search in Google Scholar

2 Kadam SS, Tripathi P, Jagtap R, Kapoor R, Kadam T, Bhandarkar P, et al. Modified Radical Mastectomy vs Breast-Conserving Surgery: Current Clinical Practice in Women with Early Stage Breast Cancer at a Corporate Tertiary Cancer Center in India. Indian J Surg Oncol. 2022;13(2):322-8. DOI: 10.1007/s13193-021-01457-8 Search in Google Scholar

3 Slamon DJ, Neven P, Chia S, Jerusalem G, De Laurentiis M, Im S, et al Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival. Ann Oncol. 2021;32(8):1015-24. DOI: 10.1016/j.annonc.2021.05.353 Search in Google Scholar

4 Horisawa N, Adachi Y, Takatsuka D, Nozawa K, Endo Y, Ozaki Y, et al. The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status. Breast Cancer. 2022;29(2):234-41. DOI: 10.1007/s12282-021-01303-3 Search in Google Scholar

5 Fleming GF, Pagani O, Regan MM, Walley BA, Francis PA. Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study. Ann Oncol. 2022;33(6):658. DOI: 10.1016/j. annonc.2022.03.003 Search in Google Scholar

6 Chen B, Sang Y, Song X, Zhang D, Wang L, Zhao W, et al. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28. Theranostics. 2021;11(8):3932-47. DOI: 10.7150/thno.53412 Search in Google Scholar

7 Peng X, Zhang Z, Mo Y, Liu J, Wang S, Liu H. Bioinformatics Analysis of Choriocarcinoma-Related MicroRNA-Transcription Factor-Target Gene Regulatory Networks and Validation of Key miRNAs. Onco Targets Ther. 2021;14:3903-19. DOI: 10.2147/OTT.S311291 Search in Google Scholar

8 Ghasabi M, Mansoori B, Mohammadi A, Duijf PH, Shomali N, Shirafkan N, et al. MicroRNAs in cancer drug resistance: Basic evidence and clinical applications. J Cell Physiol. 2019;234:2152-68. DOI: 10.1002/jcp.26810 Search in Google Scholar

9 Frontiers Editorial Office. Retraction: microRNA-155 Modulates Hepatic Stellate Cell Proliferation, Apoptosis, and Cell Cycle Progression in Rats With Alcoholic Hepatitis via the MAPK Signaling Pathway Through Targeting SOCS1. Front Pharmacol. 2022;12:840009. DOI: 10.3389/fphar.2021.840009 Search in Google Scholar

10 Wen Q, Wang Y, Pan Q, Tian R, Zhang D, Qin G, et al. MicroRNA-155-5p promotes neuroinflammation and central sensitization via inhibiting SIRT1 in a nitroglycerin-induced chronic migraine mouse model. J Neuroinflammation. 2021;18(1):287. DOI: 10.1186/s12974-021-02342-5 Search in Google Scholar

11 Danza K, Porcelli L, De Summa S, Di Fonte R, Pilato B, Lacalamita R, et al. The ERRα-VDR axis promotes calcitriol degradation and estrogen signaling in breast cancer cells, while VDR-CYP24A1-ERRα overexpression correlates with poor prognosis in patients with basal-like breast cancer. Mol Oncol. 2022;16(4):904-20. DOI: 10.1002/1878-0261.13013 Search in Google Scholar

12 Zhang S, Liu X, Liu J, Guo H, Xu H, Zhang G. PGC-1 alpha interacts with microRNA-217 to functionally regulate breast cancer cell proliferation. Biomed Pharmacother. 2017;85:541-8. DOI: 10.1016/j.biopha.2016.11.062 Search in Google Scholar

13 Hu X, Li T, Wang B, Zhang J, Yu X, Shao Z. Comparison of 4th ESOESMO international consensus guidelines for advance breast cancer and Chinese anti-cancer association committee of Breast Cancer Society guideline. Breast. 2019;45:36-42. DOI: 10.1016/j. breast.2019.02.009 Search in Google Scholar

14 Moldovan JB, Wang Y, Shuman S, Mills RE, Moran JV. RNA ligation precedes the retrotransposition of U6/LINE-1 chimeric RNA. Proc Natl Acad Sci U S A. 2019;116(41):20612-22. DOI: 10.1073/pnas.1805404116 Search in Google Scholar

15 Grabher BJ. Breast Cancer: Evaluating Tumor Estrogen Receptor Status with Molecular Imaging to Increase Response to Therapy and Improve Patient Outcomes. J Nucl Med Technol. 2020;48(3):191-201. DOI: 10.2967/jnmt.119.239020 Search in Google Scholar

16 Xie X, Li H, Wang C, Li W, Xie D, Li M, et al. Effect of modified radical mastectomy combined with neo-adjuvant chemotherapy on postoperative recurrence rate, negative emotion, and life quality of patients with breast cancer. Am J Transl Res. 2022;14(1):460-7. Search in Google Scholar

17 Finn RS, Boer K, Bondarenko I, Patel R, Pinter T, Schmidt M, et al. Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1, TRIO-18). Breast Cancer Res Treat. 2020;183(2):419-28. DOI: 10.1007/s10549-020-05755-7 Search in Google Scholar

18 Ding Y, Wu W, Ma Z, Shao X, Zhang M, Wang Z. Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis. Medicine. 2021;100(22):e25964. DOI: 10.1097/MD.0000000000025964 Search in Google Scholar

19 Wu K, Feng J, Lyu F, Xing F, Sharma S, Liu Y, et al. Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer. Nat Commun. 2021;12(1):5196. DOI: 10.1038/s41467-021-25473-y Search in Google Scholar

20 Murugesan M, Premkumar K. Integrative miRNA-mRNA functional analysis identifies miR-182 as a potential prognostic biomarker in breast cancer. Mol Omics. 2021;17(4):533-43. DOI: 10.1039/D0MO00160K Search in Google Scholar

21 Bajaj R, Tripathi R, Sridhar TS, Korlimarla A, Choudhury KD, Suryavanshi M, et al. Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer. PloS One. 2020;15(11):e0242190. DOI: 10.1371/journal. pone.0242190 Search in Google Scholar

22 Khalighfard S, Alizadeh AM, Irani S, Omranipour R. Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients. Sci Rep. 2018;8:17981. DOI: 10.1038/s41598-018-36321-3 Search in Google Scholar

23 Wang F, Wang J, Zhang H, Fu B, Zhang Y, Jia Q, et al. Diagnostic value of circulating miR-155 for breast cancer: a meta-analysis. Front Oncol. 2024;14:1374674. DOI: 10.3389/fonc.2024.1374674 Search in Google Scholar

24 Hamidi AA, Zangoue M, Kashani D, Zangouei AS, Rahimi HR, Abbaszadegan MR, et al. MicroRNA-217: a therapeutic and diagnostic tumor marker. Exp Rev Mol Diagn. 2022;22(1):61-76. DOI: 10.1080/14737159.2022.2017284 Search in Google Scholar

25 Fahad Ullah M. Breast cancer: current perspectives on the disease status. In: Breast cancer metastasis and drug resistance: challenges and progress. 2019; pp. 51-64. DOI: 10.1007/978-3-030-20301-6_4 Search in Google Scholar

26 Song SE, Cho KR, Cho Y, Kim K, Jung SP, Seo BK, et al. Machine learning with multiparametric breast MRI for prediction of Ki-67 and histologic grade in early-stage luminal breast cancer. Eur Radiol. 2022;32(2):853-63. DOI: 10.1007/s00330-021-08127-x Search in Google Scholar

27 Chen Y, Wu N, Liu L, Dong H, Wu C. Correlation between microRNA-21, microRNA-206 and estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 in breast cancer. Clin Biochem. 2019;71:52-7. DOI: 10.1016/j. clinbiochem.2019.07.002 Search in Google Scholar

28 Kalinina T, Kononchuk V, Alekseenok E, Obukhova D, Sidorov S, Strunkin D, et al. Expression of estrogen receptor-and progesterone receptor-regulating microRNAs in breast cancer. Genes. 2021;12(4):582. DOI: 10.3390/genes12040582 Search in Google Scholar